1. |
Naguib MA, Dob DP, Gatzoulis MA. A functional understanding of moderate to complex congenital heart disease and the impact of pregnancy. PartⅡ:tetralogy of Fallot, Eisenmenger's syndrome and the Fontan operation. Int J Obstet Anesth, 2010, 19(3):306-312.
|
2. |
Kogon B. Is the extracardiac conduit the preferred Fontan approach for patients with univentricular hearts? The extracardiac conduit is the preferred Fontan approach for patients with univentricular hearts. Circulation, 2012, 126(21):2511-2515.
|
3. |
Naito Y, Rocco K, Kurobe H, et al. Tissue engineering in the vasculature. Anat Rec (Hoboken), 2014, 297(1):83-97.
|
4. |
Iyengar AJ, Winlaw DS, Galati JC, et al. Trends in Fontan surgery and risk factors for early adverse outcomes after Fontan surgery:The Austral ia and New Zealand Fontan Registry experience. J Thorac Cardiovasc Surg, 2014, 148(2):566-575.
|
5. |
Patterson JT, Gilliland T, Maxfield MW, et al. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease:from the bench to the cl inic and back again. Regen Med, 2012, 7(3):409-419.
|
6. |
Shinoka T, Breuer C. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J Biol Med, 2008, 81(4):161-166.
|
7. |
Naito Y, Shinoka T, Duncan D, et al. Vascular tissue engineering:towards the next generation vascular grafts. Adv Drug Deliv Rev, 2011, 63(4-5):312-323.
|
8. |
Zou Y, Zhang Y. Mechanical evaluation of decellularized porcine thoracic aorta. J Surg Res, 2012, 175(2):359-368.
|
9. |
Bader A, Steinhoff G, Strobl K, et al. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation, 2000, 70(1):7-14.
|
10. |
Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material:Structure and function. Acta Biomater, 2009, 5(1):1-13.
|
11. |
Weber B, Emmert MY, Schoenauer R, et al. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol, 2011, 33(3):307-315.
|
12. |
马良龙, 黄惠民, 李建华, 等.新法制备动脉脱细胞基质的实验研究.中华小儿外科杂志, 2009, 30(7):468-471.
|
13. |
张建, 吴英锋, 陈亮.猪主动脉脱细胞基质的简化制备及生物学评价.中国修复重建外科杂志, 2008, 22(3):364-369.
|
14. |
黄华梅, 谢德明, 罗洁芳.应用脱细胞血管基质构建组织工程血管的初步研究.中国病理生理杂志, 2008, 24(4):792-796.
|
15. |
Yang M, Chen CZ, Wang XN, et al. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res B Appl Biomater, 2009, 91(1):354-361.
|
16. |
Cebotari S, Tudorache I, Jaekel T, et al. Detergent decellularization of heart valves for tissue engineering:toxicological effects of residual detergents on human endothelial cells. Artif Organs, 2010, 34(3):206-210.
|
17. |
Boer U, Lohrenz A, Klingenberg M, et al. The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts. Biomaterials, 2011, 32(36):9730-9737.
|
18. |
Cebotari S, Tudorache I, Ciubotaru A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults:early report. Circulation, 2011, 124(11 Suppl):S115-S123.
|
19. |
Bloch O, Erdbrugger W, Volker W, et al. Extracellular matrix in deoxycholic acid decellularized aortic heart valves. Med Sci Monit, 2012, 18(12):BR487-R492.
|
20. |
Honge JL, Funder J, Hansen E, et al. Recellularization of aortic valves in pigs. Eur J Cardiothorac Surg. 2011, 39(6):829-834.
|
21. |
Tudorache I, Cebotari S, Sturz G, et al. Tissue engineering of heart valves:biomechanical and morphological properties of decellularized heart valves. J Heart Valve Dis. 2007, 16(5):567-573, 574.
|
22. |
Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials, 2007, 28(25):3587-3593.
|
23. |
Knight RL, Wilcox HE, Korossis SA, et al. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng H, 2008, 222(1):129-143.
|
24. |
Galil i U. Theα-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie, 2001, 83(7):557-563.
|
25. |
Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes:progress toward understanding and prevention. Ann Thorac Surg, 2005, 79(3):1072-1080.
|
26. |
Cicha I, Ruffer A, Cesnjevar R, et al. Early obstruction of decellularized xenogenic valves in pediatric patients:involvement of inflammatory and fibroproliferative processes. Cardiovasc Pathol, 2011, 20(4):222-231.
|
27. |
Brown BN, Ratner BD, Goodman SB, et al. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials, 2012, 33(15):3792-3802.
|
28. |
Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol, 2008, 20(2):109-116.
|